ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

NCT07531745 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ionis Pharmaceuticals, Inc.